Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study
Our study suggests that MHT use increases the risk of incident and fatal overall and luminal A-like, and incident luminal B-like breast cancer but does not decrease overall survival among patients with breast cancer. Further research is needed to elucidate the mechanisms underlying MHT use and breast cancer lethality, and to explore whether MHT use among patients with TNBC is indeed free from harm.
Authors
- Marit Busund (ORCID: https://orcid.org/0000-0001-5767-3204)
- Eiliv Lund (ORCID: https://orcid.org/0000-0002-8071-8711)
- Giske Ursin (ORCID: https://orcid.org/0000-0002-0835-9507)
- S Chen (ORCID: https://orcid.org/0000-0001-5774-7058)
- Charlotta Rylander
Institutions
- University of Southern California (US)
- Norwegian Institute of Public Health (NO)
- University of Oslo (NO)
- Cancer Registry of Norway (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1186/s13058-024-01897-4
- Citations
- 7
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 3.85
Funders
- Universitetet i Tromsø